Consumer Sentiment Falls to Record Low in May as Iran Conflict Spurs Inflation Concerns Kasho Targets Singapore for Shiruko Sand Expansion into Southeast Asia Michael Burry Warns SECs CryptoStyle Trading Plan Could Spell Trouble for Investors Technical Indicators Point to Bullish Bias in Intermediate Term Apollo Global and Blackstone Reportedly Working on 36 Billion Debt Financing for Anthropic PL Asset Management CIO Sees Opportunity in Indian Equities Amid Sentiment Weakness Provident Financial Holdings Inc PROV Q1 2026 Earnings EPS Misses Estimates as Stock Barely Moves BG Q1 2026 Earnings Strong EPS Surprise as Agribusiness Margins Improve MGRX Q3 2025 Earnings Narrowing Losses as Strategic Pivot Gains Momentum DouYu Q4 2025 Earnings EPS Surges Past Estimates Despite Revenue Disclosures RLGT Q1 2026 Earnings EPS Surpasses Estimates with 659 Beat NOW Q1 2026 Earnings Slight EPS Miss Overshadowed by Positive Stock Reaction Icahn Enterprises IEP Holds Steady Near 755 as Trading Volume Remains Subdued Once Upon a Farm PBC OFRM Edges Higher as Shares Hold Above Key Support Diversified Healthcare Trust DHC Slips 169 Navigating Key Support Levels Bitfarms Ltd BITF Holds Steady at 198 Key Support and Resistance Levels in Focus Peakstone Realty Trust PKST Holds Steady Near Support Amid Low Volatility Constellation Brands Analyst Estimates and Ratings Market Sentiment Overview ES Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Movement Templeton Emerging Markets Fund EMF Gains 144 as Emerging Market Sentiment Improves American Shared Hospital Services AMS Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges RxSight Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Data Unavailable RBKB Q1 2026 Earnings EPS of 020 Reported Amid Stock Decline Via Transportation Inc VIA Q1 2026 Earnings EPS Beat Exceeds Estimates by 1319 DIS Q1 2026 Earnings EPS Beats Estimates by 437 Amid CostCutting and Streaming Progress YUMC Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Operational Resilience XBIO Q2 2025 Earnings Loss Narrows Despite No Revenue as Biotech Advances Pipeline